HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigeto Yamawaki Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

6/2020The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigeto Yamawaki Research Topics

Disease

11Major Depressive Disorder (Major Depressive Disorders)
01/2021 - 10/2006
11Schizophrenia (Dementia Praecox)
06/2020 - 01/2002
5Mental Disorders (Mental Disorder)
01/2020 - 01/2005
5Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
09/2013 - 06/2005
5Neoplasms (Cancer)
10/2011 - 11/2002
4Inflammation (Inflammations)
01/2020 - 01/2016
4Mood Disorders (Mood Disorder)
01/2016 - 02/2002
3Stroke (Strokes)
04/2021 - 10/2007
3Pain (Aches)
01/2021 - 01/2011
3Dementia (Dementias)
11/2013 - 01/2004
2Neuroinflammatory Diseases
01/2021 - 01/2020
2Psychotic Disorders (Schizoaffective Disorder)
06/2020 - 06/2016
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2019 - 06/2015
2Dyskinesias (Dyskinesia)
01/2018 - 05/2012
2Chronic Kidney Failure (Chronic Renal Failure)
11/2013 - 10/2011
2Bipolar Disorder (Manic Depressive Psychosis)
03/2013 - 10/2006
2Hyperprolactinemia
12/2012 - 11/2004
1Endotoxemia
01/2021
1Tardive Dyskinesia
06/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2020
1Brain Injuries (Brain Injury)
01/2020
1Anorexia
12/2019
1Alcoholism (Alcohol Abuse)
07/2019
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
07/2019
1Anhedonia
01/2019
1Depressive Disorder (Melancholia)
01/2017
1Mania (Manias)
06/2016
1Treatment-Resistant Depressive Disorder
01/2016
1Seizures (Absence Seizure)
03/2013
1Panic Disorder (Panic Attack)
01/2012
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2012
1Lung Neoplasms (Lung Cancer)
10/2011
1Weight Gain
08/2008
1Vascular Depression
04/2008
1Neuroleptic Malignant Syndrome
08/2007
1Glioma (Gliomas)
04/2007
1Wounds and Injuries (Trauma)
12/2006

Drug/Important Bio-Agent (IBA)

10Antidepressive Agents (Antidepressants)IBA
10/2020 - 02/2002
10Antipsychotic Agents (Antipsychotics)IBA
06/2020 - 03/2002
7Pharmaceutical PreparationsIBA
01/2021 - 01/2002
4Biomarkers (Surrogate Marker)IBA
01/2020 - 12/2002
4Cholinergic Antagonists (Anticholinergics)IBA
01/2018 - 01/2002
3Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2019
3Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2013 - 04/2011
3Risperidone (Risperdal Consta)FDA LinkGeneric
12/2012 - 03/2002
3Olanzapine (Zyprexa)FDA Link
08/2008 - 11/2004
3Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
04/2007 - 03/2004
2EscitalopramFDA Link
10/2020 - 04/2016
2CytokinesIBA
12/2019 - 11/2002
2Valproic Acid (Depakote)FDA LinkGeneric
01/2017 - 03/2013
2LithiumIBA
01/2017 - 11/2002
2Histone Deacetylase InhibitorsIBA
01/2016 - 09/2013
2Yi-Gan SanIBA
11/2013 - 10/2011
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
09/2013 - 08/2006
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2013 - 08/2008
2Serotonin (5 Hydroxytryptamine)IBA
01/2012 - 03/2004
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2012 - 01/2009
2Indicators and Reagents (Reagents)IBA
03/2011 - 11/2002
2Biological ProductsIBA
01/2011 - 01/2005
2Paroxetine (Paxil)FDA LinkGeneric
01/2009 - 12/2006
2Quetiapine Fumarate (Seroquel)FDA Link
11/2004 - 01/2004
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
04/2021
1Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2020
1ONO-2952IBA
01/2020
1NF-kappa B (NF-kB)IBA
12/2019
1LipopolysaccharidesIBA
12/2019
1Type C PhospholipasesIBA
12/2019
1Phosphotransferases (Kinase)IBA
12/2019
1lysophosphatidic acidIBA
01/2019
1ImmunosorbentsIBA
01/2019
1EnzymesIBA
01/2019
1Histones (Histone)IBA
01/2018
1Uric Acid (Urate)IBA
01/2018
1Triglycerides (Triacylglycerol)IBA
01/2018
1CholesterolIBA
01/2018
1Matrix Metalloproteinases (MMPs)IBA
01/2016
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2016
1Tissue Inhibitor of Metalloproteinase-2IBA
01/2016
1Hypnotics and Sedatives (Sedatives)IBA
06/2015
1GABA-A Receptors (GABA(A) Receptor)IBA
06/2015
1Histamine AgentsIBA
06/2015
1N-Methylaspartate (NMDA)IBA
09/2013
1VorinostatFDA Link
09/2013
1Aripiprazole (Abilify)FDA Link
12/2012
1GlucocorticoidsIBA
01/2009
1Hormones (Hormone)IBA
08/2008
1GhrelinIBA
08/2008
1Cycloserine (Seromycin)FDA Link
08/2008
1Methylphenidate (Ritalin)FDA LinkGeneric
04/2008

Therapy/Procedure

2Length of Stay
01/2018 - 05/2012
2Renal Dialysis (Hemodialysis)
11/2013 - 10/2011
2Therapeutics
03/2013 - 07/2004
1Blood Pressure Monitors
01/2021
1Neurofeedback
01/2020
1Transplantation
07/2019
1Liver Transplantation
07/2019
1Drug Therapy (Chemotherapy)
01/2017
1Aftercare (After-Treatment)
12/2015
1Complementary Therapies (Alternative Medicine)
06/2015
1Activities of Daily Living (ADL)
10/2007